Related content

Prospects for control of African trypanosomiasis by tsetse vector manipulation

By Aksoy S.   O'Neill S.L.   Maudlin I.   Dale C.   Robinson A.S.  

Parasitology Today, Vol. 17, Iss. 1, 2001-01 ,pp. : 29-35

Elsevier

Access to resources Recommend Favorite

The programme against African trypanosomiasis: aims, objectives and achievements

By Hursey B.S.  

Parasitology Today, Vol. 17, Iss. 1, 2001-01 ,pp. : 2-3

Elsevier

Access to resources Recommend Favorite

INNATE RESISTANCE TO EXPERIMENTAL AFRICAN TRYPANOSOMIASIS: DIFFERENCES IN CYTOKINE (TNF-α, IL-6, IL-10 AND IL-12) PRODUCTION BY BONE MARROW-DERIVED MACROPHAGES FROM RESISTANT AND SUSCEPTIBLE MICE

By Kaushik R.S.   Uzonna J.E.   Zhang Y.   Gordon J.R.   Tabel H.  

Cytokine, Vol. 12, Iss. 7, 2000-07 ,pp. : 1024-1034

Academic Press

Access to resources Recommend Favorite

Human African trypanosomiasis: Potential therapeutic benefits of an alternative suramin and melarsoprol regimen

By Jennings F.W.   Rodgers J.   Bradley B.   Gettinby G.   Kennedy P.G.E.   Murray M.  

Parasitology International, Vol. 51, Iss. 4, 2002-12 ,pp. : 381-388

Elsevier

Access to resources Recommend Favorite

New drugs for the treatment of human African trypanosomiasis: research and development

By Keiser J.   Burri C.   Stich A.  

Parasitology Today, Vol. 17, Iss. 1, 2001-01 ,pp. : 42-49

Elsevier

Access to resources Recommend Favorite